Sopharma AD is a leading Bulgarian pharmaceutical company, established in 1933, specializing in the research, development, manufacturing, and marketing of a diverse range of medicinal products, active pharmaceutical ingredients (APIs), and food supplements. It is a key player in the regional healthcare sector, serving domestic and international markets.

Manufacturing and Product Range

Sopharma AD operates state-of-the-art manufacturing facilities in Bulgaria, adhering to strict Good Manufacturing Practice (GMP) standards. Its extensive product portfolio includes a wide array of prescription and over-the-counter (OTC) medicines, covering key therapeutic areas like cardiology and pulmonology. The company is known for its traditional herbal-based products and a robust pipeline of generic drugs, ensuring broad access to essential treatments.

Market Reach and Strategic Focus

With a significant presence in the Bulgarian market, Sopharma AD has successfully expanded its operations to over 40 international markets, including Eastern Europe and CIS countries. The company maintains a strong focus on research and development, continuously investing in new formulations and innovative drug delivery systems. This strategic emphasis on innovation and high-quality production has established Sopharma as a reliable pharmaceutical supplier globally.